首页> 外国专利> METHOD FOR CALCULATING THE DOSE OF HAEMATOPOIESIS PRECURSOR CELLS IN A LEUKOCYTAPHERESIS PRODUCT BY TAKING INTO ACCOUNT THE CHANGE IN THE INTEGRITY OF CELL MEMBRANES DURING STORAGE

METHOD FOR CALCULATING THE DOSE OF HAEMATOPOIESIS PRECURSOR CELLS IN A LEUKOCYTAPHERESIS PRODUCT BY TAKING INTO ACCOUNT THE CHANGE IN THE INTEGRITY OF CELL MEMBRANES DURING STORAGE

机译:通过考虑存储过程中细胞膜完整性的变化计算白细胞生成素产品中造血前体细胞剂量的方法

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, namely immunology, and can be used for calculating transplantation dose of CD34-positive progenitor cells in a donor leukocytapheresis product. Calculation method involves labeling cell material with fluorochrome-conjugated monoclonal antibodies to CD34 and CD45 markers with simultaneous staining with fluorescent DNA-tropic dye 7-aminoactinomycin D. Further, CD34-positive haematopoiesis progenitors contents are determined by haemocytometry and laser flow cytofluorometry. When calculating a transplantation dose, factors of membrane integrity change of haemopoietic stem cells – 0.985, 0.971, 0.958, 0.947 and 0.930, respectively, for 1, 2, 3, 4 and 5th days storage of cell material before transplantation to recipient at temperature plus 2 – plus 6 °C. Calculation is carried out by formulas 1 and 2:; ,; ,;where CD34+ rel. – relative content of CD34+ progenitor cells of haematopoiesis in a leukocytapheresis product; CD34 abs. is number of progenitor cells, which is defined as the number of events with high CD34 antigen expression, low CD45 antigen expression and low granularity, calculated in the polygonal region "HSC 1"; kn is the CD34+ cell membrane integrity change coefficient on the n-th storage day; CD45 abs. – number of leukocytes in the sample, which is determined as the number of CD45 antigen-positive events counted in the rectangular region "CD45+"; Dose of CD34+ – transplant dose of CD34+ haematopoiesis progenitor cells in leukocytapheresis product; C (leuk.) – concentration of leukocytes in sample, cells/mcl; V – volume of leukocytapheresis product, mcl; m is body weight of recipient of CD34-positive hematopoiesis progenitor cells, kg.;EFFECT: use of the given method allows calculating dose of CD34+ cells considering change of integrity of their membranes during storage in conditions of cooling before transplantation.;1 cl, 7 dwg, 1 tbl, 2 ex
机译:技术领域本发明涉及医学,即免疫学,可用于计算供体白细胞减少症产品中CD34阳性祖细胞的移植剂量。计算方法包括用荧光染料偶联的针对CD34和CD45标记的单克隆抗体标记细胞材料,同时用荧光DNA嗜性染料7-氨基放线菌素D染色。此外,通过血细胞计数法和激光流式细胞仪确定CD34阳性造血祖细胞的含量。在计算移植剂量时,造血干细胞分别在第1、2、3、4和5天存储的造血干细胞膜完整性变化的因素分别为0.985、0.971、0.958、0.947和0.930。材料在移植到受体之前的温度为2 + 6°C。通过公式1和2进行计算; ,;其中CD34 + 相对。 –白细胞减少症产品中造血的CD34 + 祖细胞的相对含量; CD34绝对值是祖细胞的数目,其定义为在多边形区域“ HSC 1”中计算出的具有高CD34抗原表达,低CD45抗原表达和低粒度的事件数; k n 是第n个储存日的CD34 + 细胞膜完整性变化系数; CD45绝对–样品中的白细胞数目,其确定为在矩形区域“ CD45 + ”中计数的CD45抗原阳性事件的数目; CD34 + 的剂量–白细胞生成产品中CD34 + 造血祖细胞的移植剂量; C(白细胞)–样品中白细胞的浓度,细胞/ mcl; V –白细胞去除产物的体积,mcl; m是CD34阳性造血祖细胞受体的体重,kg。效果:使用给定的方法可以计算CD34 + 细胞的剂量,考虑到在以下条件下储存过程中其膜完整性的变化。移植前冷却。; 1 cl,7 dwg,1 tbl,2 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号